Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53 .

Tytuł:
Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53 .
Autorzy:
Leu JI; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Murphy ME; Program in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104 .
George DL; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; .
Źródło:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Oct 27; Vol. 117 (43), pp. 26804-26811. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: Washington, DC : National Academy of Sciences
MeSH Terms:
Ferroptosis*
Genes, p53*
Oxidation-Reduction*
Activating Transcription Factor 4/*metabolism
Sulfhydryl Compounds/*metabolism
Animals ; Cell Line ; Coenzyme A/metabolism ; Glutathione/metabolism ; Glycolysis ; Homeostasis ; Humans ; Male ; Mice ; Protein Processing, Post-Translational
References:
Biochemistry. 2019 Sep 3;58(35):3669-3682. (PMID: 31386812)
Genes Dev. 2016 Apr 15;30(8):918-30. (PMID: 27034505)
Br J Pharmacol. 2019 Feb;176(4):583-593. (PMID: 30007014)
IUBMB Life. 2019 Jan;71(1):45-56. (PMID: 30321484)
Mol Cell. 2016 Jun 16;62(6):890-902. (PMID: 27264869)
Biochem Mol Biol Int. 1994 Oct;34(4):723-7. (PMID: 7866298)
J Biol Chem. 2005 Jun 24;280(25):24245-51. (PMID: 15851479)
NPJ Breast Cancer. 2017 Feb 27;3:5. (PMID: 28649645)
Sci Adv. 2019 Jan 02;5(1):eaau7314. (PMID: 30613774)
Cell Chem Biol. 2020 Apr 16;27(4):365-375. (PMID: 32294465)
Trends Biochem Sci. 2014 Aug;39(8):347-54. (PMID: 25037503)
Biomed Pharmacother. 2019 Jan;109:2043-2053. (PMID: 30551460)
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383. (PMID: 32231263)
Cell Metab. 2019 Nov 5;30(5):865-876.e5. (PMID: 31607565)
Front Neurosci. 2018 Apr 20;12:214. (PMID: 29731704)
Cell Death Differ. 2006 Jun;13(6):916-20. (PMID: 16557270)
Biochem J. 2017 Jul 11;474(14):2489-2508. (PMID: 28341808)
Cell Death Differ. 2016 Feb;23(2):270-8. (PMID: 26184909)
Nat Chem Biol. 2012 Oct;8(10):839-47. (PMID: 22922757)
Cell Chem Biol. 2020 Apr 16;27(4):376-386. (PMID: 32220334)
Trends Pharmacol Sci. 2018 May;39(5):513-524. (PMID: 29530337)
Annu Rev Cancer Biol. 2017 Mar;1:185-201. (PMID: 30775651)
Mol Cell Oncol. 2015 Oct 06;3(2):e1091059. (PMID: 27308611)
Cell Rep. 2016 Oct 4;17(2):366-373. (PMID: 27705786)
J Exp Med. 2008 May 12;205(5):1227-42. (PMID: 18458112)
Biochem J. 1951 Jun;49(1):1-5. (PMID: 14848019)
Nat Commun. 2020 Jan 24;11(1):473. (PMID: 31980600)
Free Radic Res. 2011 Jan;45(1):3-15. (PMID: 20815784)
J Mol Cell Biol. 2019 Apr 1;11(4):330-341. (PMID: 30892598)
Cancer Res. 1993 Oct 1;53(19):4469-73. (PMID: 8402615)
Redox Biol. 2020 May;32:101472. (PMID: 32171726)
Nature. 2015 Jan 8;517(7533):170-3. (PMID: 25567281)
Am J Physiol. 1981 Apr;240(4):H606-11. (PMID: 7013504)
Mol Cell. 2015 Jul 16;59(2):298-308. (PMID: 26166707)
Biochemistry. 2007 Jul 3;46(26):7765-80. (PMID: 17555331)
Free Radic Biol Med. 2019 Aug 20;140:14-27. (PMID: 31201851)
Front Endocrinol (Lausanne). 2018 Apr 11;9:124. (PMID: 29695998)
Biochem Soc Trans. 2019 Feb 28;47(1):469-476. (PMID: 30783014)
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1067-76. (PMID: 25713368)
Cell Metab. 2018 Sep 4;28(3):490-503.e7. (PMID: 30043752)
Nat Rev Mol Cell Biol. 2014 Jun;15(6):411-21. (PMID: 24854789)
Biochem Soc Trans. 2018 Jun 19;46(3):721-728. (PMID: 29802218)
Cell Cycle. 2016 Oct;15(19):2557-2560. (PMID: 27484708)
Elife. 2014 May 20;3:e02523. (PMID: 24844246)
Biochemistry (Mosc). 2010 Dec;75(12):1444-9. (PMID: 21314614)
J Biol Chem. 2014 May 2;289(18):12189-94. (PMID: 24637025)
Cell Chem Biol. 2020 May 21;27(5):479-498. (PMID: 32243811)
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8390-8396. (PMID: 30962386)
Nat Rev Cancer. 2009 Feb;9(2):95-107. (PMID: 19165225)
Cell Metab. 2013 Nov 5;18(5):617-33. (PMID: 23954639)
Metabolites. 2019 Apr 26;9(5):. (PMID: 31027329)
FEBS Open Bio. 2018 Nov 28;9(1):53-73. (PMID: 30652074)
Science. 2020 Apr 3;368(6486):85-89. (PMID: 32241947)
Mol Cell. 2019 Jan 17;73(2):354-363.e3. (PMID: 30581146)
Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8843-8. (PMID: 27436896)
Nature. 2015 Apr 2;520(7545):57-62. (PMID: 25799988)
PLoS One. 2012;7(10):e47889. (PMID: 23112865)
EMBO Rep. 2016 Dec;17(12):1721-1730. (PMID: 27856534)
Annu Rev Biochem. 2008;77:557-82. (PMID: 18410249)
Grant Information:
P01 CA114046 United States CA NCI NIH HHS; P01 CA098101 United States CA NCI NIH HHS; R01 CA102184 United States CA NCI NIH HHS; P01 DK049210 United States DK NIDDK NIH HHS; R01 CA139319 United States CA NCI NIH HHS; P30 DK050306 United States DK NIDDK NIH HHS; P30 CA010815 United States CA NCI NIH HHS
Contributed Indexing:
Keywords: ATF4; coenzyme A; cysteine modifications; ferroptosis; p53
Substance Nomenclature:
0 (Sulfhydryl Compounds)
145891-90-3 (Activating Transcription Factor 4)
GAN16C9B8O (Glutathione)
SAA04E81UX (Coenzyme A)
Entry Date(s):
Date Created: 20201015 Date Completed: 20201217 Latest Revision: 20210414
Update Code:
20240105
PubMed Central ID:
PMC7604449
DOI:
10.1073/pnas.2009943117
PMID:
33055209
Czasopismo naukowe
The p53 tumor suppressor protein is a transcription factor and master stress response mediator, and it is subject to reduction-oxidation (redox)-dependent regulation. The P47S variant of TP53 , which exists primarily in African-descent populations, associates with an elevated abundance of low molecular weight (LMW) thiols, including glutathione (GSH) and coenzyme A (CoA). Here we show that S47 and P47 cells exhibit distinct metabolic profiles, controlled by their different redox states and expression of Activating Transcription Factor-4 (ATF4). We find that S47 cells exhibit decreased catabolic glycolysis but increased use of the pentose phosphate pathway (PPP), and an enhanced abundance of the antioxidant, NADPH. We identify ATF4 as differentially expressed in P47 and S47 cells and show that ATF4 can reverse the redox status and rescue metabolism of S47 cells, as well as increase sensitivity to ferroptosis. This adaptive metabolic switch is rapid, reversible, and accompanied by thiol-mediated changes in the structures and activities of key glycolytic signaling pathway proteins, including GAPDH and G6PD. The results presented here unveil the important functional interplay among pathways regulating thiol-redox status, metabolic adaptation, and cellular responses to oxidative stress.
Competing Interests: The authors declare no competing interest.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies